Patents : |  |
| US Patent No. | Title |
| 7601706 | Bile-acid conjugates providing for sustained systemic concentration of drugs
|
| 7604799 | EphA4 Antibodies
|
| 7604993 | Combined regulation of neural cell production
|
| 7605154 | Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors
|
| 7605164 | Compositions and methods for treating heart failure
|
| 7605166 | Methods and compositions for treating rheumatoid arthritis
|
| 7605171 | (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists
|
| 7605172 | Thiazolo-naphthyl acids
|
| 7607440 | Methods and apparatus for surgical planning
|
| 7608077 | Method and apparatus for spinal distraction and fusion
|
| 7608082 | Surgical seal for use in a surgical access apparatus
|
| 7604648 | Direct vision port site dissector
|
| 7604634 | Transmural ablation device
|
| 7604633 | Moisture transport system for contact electrocoagulation
|
| 7601713 | Kinase inhibitors and their uses
|
| 7601716 | Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
|
| 7601721 | Substituted heterocyclic compounds
|
| 7601726 | Substituted pyrazolo[3,4-d]pyrimidines as p38 MAP kinase inhibitors
|
| 7601727 | Pyrrolo[2,3-d]pyrimidine compounds
|
| 7601745 | Heterocyclic NF-kB inhibitors
|
| 7601746 | Compounds exhibiting thrombopoietin receptor agonism
|
| 7601856 | Benzofurans as potassium ion channel modulators
|
| 7601876 | Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis
|
| 7604185 | Generation of therapeutic microfoam
|
| 7608247 | Use of outer membrane protein a in treatment/prevention/diagnosis of bacterial infection in central nervous system and/or peripheral blood circulation
|
| 7608297 | Procedure for the realisation of ceramic manufactures, in particular, porcelain stoneware tiles and trim pieces, with anti pollution and anti-bacterial properties and products thereby obtained
|
| 7615610 | Modified trafficking patterns for arrestin and G-protein-coupled receptors via arrestin-ubiquitin chimera
|
| 7615649 | Synthesis of polycyclic procyanidins
|
| 7618399 | Pneumoperitoneum needle
|
| 7618625 | Compositions comprising large and small binding fragments of antibodies against the same toxin
|
| 7618629 | Manipulation of cytokine levels using CD83 gene products
|
| 7618945 | Heteroaryl peptidomimetics as thrombin receptor antagonists
|
| 7618947 | Modulation of HIF-1 beta expression
|
| 7618958 | Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects
|
| 7618970 | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
|
| 7618983 | Bicyclic triazole .alpha.4 integrin inhibitors
|
| 7615548 | Method to inhibit ischemia and reperfusion injury
|
| 7612106 | Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
|
| 7612078 | Piperidinylamino-thieno[2,3-D] pyrimidine compounds
|
| 7608603 | Substituted pyrazolo[3,4-D]pyrimidines as p38 MAP kinase inhibitors
|
| 7608626 | Substituted indolizines and derivatives as CNS agents
|
| 7608634 | Substituted pyrrolines as kinase inhibitors
|
| 7608723 | Indole and benzimidazole derivatives
|
| 7611494 | Spray for fluent materials
|
| 7611691 | Compounds for treatment of copper overload
|
| 7612036 | Peptoid compounds
|
| 7612038 | Biglycan and related therapeutics and methods of use
|
| 7612072 | Amorphous form of a phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor
|
| 7612077 | Crystalline forms of the anti-cancer compound ZD1839
|
| 7619007 | Method and composition for administering an NMDA receptor antagonist to a subject
|
